Anbio Biotechnology NNNN
NASDAQ NNNN
$3.72 -0.01 (-0.27%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Accounts Payables (2023 - 2025)

Updated

Anbio Biotechnology (NNNN) reported Accounts Payables of $60,350 for the quarter ended Jun 30, 2025.

Analysis

Anbio Biotechnology (NNNN) Accounts Payables (2023 - 2025) Analysis & Trends

As of Dec 31, 2024, Anbio Biotechnology posted Accounts Payables of $1.63 million, up 96.5% from the prior year.

  • By year, Accounts Payables came in at $827,151 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 3.27 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 4.79 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 1.82 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 277.20 Mn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 2.70 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 1.66 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 1.23 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 6.11 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 210.50 Mn
10 Anbio Biotechnology 162.72 Mn 115.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 60,350.00
Dec 31, 2024 1.63 Mn
Dec 31, 2023 827,151.00
API Access

Anbio Biotechnology Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NNNN&period=max&api_key=YOUR_API_KEY